Visiox Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VISIOX PHARMA, and what generic alternatives to VISIOX PHARMA drugs are available?
VISIOX PHARMA has one approved drug.
There are eleven US patents protecting VISIOX PHARMA drugs.
There are one hundred and seventeen patent family members on VISIOX PHARMA drugs in thirty-two countries.
Summary for Visiox Pharma
| International Patents: | 117 |
| US Patents: | 11 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Visiox Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Visiox Pharma | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | DISCN | Yes | No | 10,179,127 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Visiox Pharma | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | DISCN | Yes | No | 9,415,038 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Visiox Pharma | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | DISCN | Yes | No | 11,666,563 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Visiox Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2019131901 | ⤷ Subscribe |
| South Korea | 102281620 | ⤷ Subscribe |
| Canada | 2757291 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
